Detail akcie Sharps Tech Rg online

Business Summary: Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Sharps Technology Inc revenues increased from $0K to $2.5M. Net loss increased from $4.8M to $99.8M. Revenues reflect Revenue, net increase from $0K to $306K. Higher net loss reflects General and administrative - Balancing v increase from $3.3M to $104.6M (expense), Payroll and consulting increase from $1.7M to $4.7M (expense), Stock-based Compensation in SGA increase from $317K to $3.3M (expense).